Treating cancer when neither chemotherapy nor transplant works
Without the most common side effects, with improvement from the first days and complete remission after 18 months in almost 70% of cases. A clinical trial of CAR-T therapies coordinated by the Hospital Cl�nic Barcelona - IDIBAPS, with the support of the”la Caixa” Foundation, has brought the word curable almost within touching distance for multiple myeloma, the second most common blood cancer in the world, thus increasing hope and quality of life for patients. “After eight years of uns...
Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=321203